A detailed history of Trust CO Of Vermont transactions in Geron Corp stock. As of the latest transaction made, Trust CO Of Vermont holds 600 shares of GERN stock, worth $2,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$2,466
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$3.1 - $5.09 $1,860 - $3,054
600 New
600 $2,000
Q3 2022

Oct 24, 2022

BUY
$1.67 - $2.94 $835 - $1,470
500 New
500 $1,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.55B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.